The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Femoston-conti 1 mg/5 mg film-coated tablets

Mylan IRE Healthcare LimitedPA2010/012/004

Main Information

Trade NameFemoston-conti 1 mg/5 mg film-coated tablets
Active SubstancesEstradiol
Dosage FormFilm-coated tablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/012/004

Group Information

ATC CodeG03FA Progestogens and estrogens, fixed combinations
G03FA14 dydrogesterone and estrogen


License statusAuthorised
Licence Issued08/12/2000
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back